XML 27 R10.htm IDEA: XBRL DOCUMENT v3.22.1
SEGMENTS
12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
SEGMENTS

4. SEGMENTS

 

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision–making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision-maker is the CEO. The Company operates in and reports four business segments: real estate, digital transformation technology, biohealth, and other business activities. The Company’s reportable segments are determined based on the services they perform and the products they sell, not on the geographic area in which they operate. The Company’s chief operating decision maker evaluates segment performance based on segment revenue. Costs excluded from segment income (loss) before taxes and reported as “Other” consist of corporate general and administrative activities which are not allocable to the four reportable segments.

 

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the years ended December 31, 2021 and 2020: 

 

                     
   Real Estate   Digital Transformation Technology   Biohealth Business   Other   Total 
                     
Year Ended December 31, 2021                         
Revenue  $14,213,379   $-   $5,543,066   $42,377   $19,798,822 
Cost of Sales   (11,073,756)   -    (214,019)   (14,039)   (11,301,814)
Gross Margin   3,139,623    -    5,329,047    28,338    8,497,008 
Operating Expenses   (1,136,031)   (183,429)   (3,624,200)   (18,547,470)   (23,491,130)
Operating Income (Loss)   2,003,592    (183,429)   1,704,847    (18,519,132)   (14,994,122)
Other Income (Expense)   (8,955)   1,286,962    (39,265,445)   (65,502,017)   (103,489,455)
Net Income (Loss) Before Income Tax   1,994,637    1,103,533    (37,560,598)   (84,021,149)   (118,483,577)

 

                     
   Real Estate   Digital Transformation Technology   Biohealth Business   Other   Total 
                     
Year Ended December 31, 2020 (As Restated)                         
Revenue  $13,643,689   $-   $2,594,511   $-   $16,238,200 
Cost of Sales   (11,779,984)   -    (305,590)   -    (12,085,574)
Gross Margin   1,863,705    -    2,288,921    -    4,152,626 
Operating Expenses   (660,647)   (54,673)   (1,545,244)   (4,076,800)   (6,337,364)
Operating Income (Loss)   1,203,058    (54,673)   743,677    (4,076,800)   (2,184,738)
Other Income (Expense)   1,983    (77)   (1,392,617)   (1,098,888)   (2,489,599)
Net Income (Loss) Before Income Tax   1,205,041    (54,750)   (648,940)   (5,175,688)   (4,674,337)
                          
December 31, 2021                         
Cash and Restricted Cash  $7,493,921   $245,780   $2,629,464   $50,433,014   $60,802,179 
Total Assets   55,465,600    2,199,466    11,056,779    115,488,298    184,210,143 
                          
December 31, 2020                         
Cash and Restricted Cash  $8,150,769   $158,058   $1,590,265   $21,836,387   $31,735,479 
Total Assets   28,954,484    158,160    524,603    78,076,498    107,713,745